Treatment of Bone Tumors in Dogs with Epodyl
Author Information
Author(s): L. N. Owen
Primary Institution: School of Veterinary Medicine, University of Cambridge
Hypothesis
Can intra-arterial injection or perfusion of Epodyl effectively treat malignant bone tumors in dogs?
Conclusion
The treatment with Epodyl resulted in tumor regression in some dogs, but the effects were often temporary and accompanied by significant side effects.
Supporting Evidence
- Regression of tumors occurred in 12 dogs but was maintained for 2 months or more in only 5.
- The longest period of regression without evidence of lung metastases was 5 months.
- Major toxic effects included considerable edema in the affected limb, leading to gangrene in some cases.
Takeaway
This study looked at how a special medicine called Epodyl can help dogs with bone tumors. Some dogs felt better for a little while, but many still got sick again.
Methodology
Epodyl was administered via intra-arterial injection or limb perfusion in dogs with malignant bone tumors, and various doses and methods were tested.
Limitations
The study had a small sample size and the results were not as effective as treatments for humans.
Participant Demographics
The study involved 17 dogs of various breeds with malignant bone tumors.
Want to read the original?
Access the complete publication on the publisher's website